Trials / Recruiting
RecruitingNCT06976424
Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in Female
Comparison of Eflornithine Cream Combined With Intense Pulsed Light Versus Intense Pulsed Light Alone for Hirsutism in Women
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 122 (estimated)
- Sponsor
- Khyber Teaching Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The study compares the effects of a cream alone and a combined effect of cream and laser for the treatment of excessive facial hairs in women .
Detailed description
Hirsuitism refers to excessive terminal hairs in females, following a distribution pattern typically associated with male. It is associated with either increase response of hair follicles to androgen or either increase level of circulating androgens.The treatment options available are topical creams like eflornithine and laser treatments for hair removal. This study aims to conduct the comparison of a eflornithine cream and intense pulsed light laser versus eflornithine cream alone for the treatment of excessive facial hairs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eflornithine Topical | Eflornithine cream will be applied to the face of group B female patients |
| RADIATION | Instense pulsed light | Intense pulse light will be applied to the face of patient of Group A on areas having increase hair. Patient will be called for a followup every month for next session. |
| DRUG | Eflornithine Topical | Eflornithine will be given to group A patient along with intense pulsed light and results will be compared to group B who recieved only Eflornithine cream |
Timeline
- Start date
- 2025-07-15
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2025-05-16
- Last updated
- 2025-07-03
Locations
3 sites across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06976424. Inclusion in this directory is not an endorsement.